glp 1 studies 2025 New GLP-1 drugs could suppress desire for more than just food, study suggests GLP-1 drugs, which have grown

, (

Your provider will help determine the most appropriate option based on your health history, goals, and lab results

Sublingual tirzepatide drops and other oral preparations may contain absorption enhancers similar to SNAC

Almost one-third (31%) of all patients dispensed the drugs in 2023 had no recorded diagnosis of either diabetes or obesity, compared to 8% in 2019

Fig 2: Evolving Competitive Landscape in GLP-1 Based Obesity Medications Abbreviations: AHI: Apnea Hyperpnea Index, CKD: Chronic Kidney Disease, MONW: Metabolic Obesity Normal Weight, OOP: Out-of-pocket, OSA: Obstructive Sleep Apnea, WRC: Weight- related comorbidity

PlexusDx monitors your progress continuously to determine if any changes serve your health goals